z-logo
open-access-imgOpen Access
Infection With the USNeisseria meningitidisUrethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea
Author(s) -
Abigail Norris Turner,
Alex M. Carter,
YihLing Tzeng,
David S. Stephens,
Morgan A. Brown,
Brandon Snyder,
Adam C. Retchless,
Xin Wang,
José A. Bazan
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab824
Subject(s) - gonorrhea , medicine , urethritis , neisseria gonorrhoeae , neisseria meningitidis , urethra , hazard ratio , neisseriaceae , neisseria , cohort , chlamydia , gynecology , urology , microbiology and biotechnology , immunology , confidence interval , antibiotics , biology , bacteria , genetics , human immunodeficiency virus (hiv)
Cross-protective immunity between Neisseria meningitidis (Nm) and Neisseria gonorrhoeae (Ng) may inform gonococcal vaccine development. Meningococcal serogroup B (MenB) outer membrane vesicle (OMV) vaccines confer modest protection against gonorrhea. However, whether urethral Nm infection protects against gonorrhea is unknown. We examined gonorrhea risk among men with US Nm urethritis clade (US_NmUC) infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom